Free Trial

Alnylam Pharmaceuticals (ALNY) SEC Filings & 10K Form

Alnylam Pharmaceuticals logo
$259.39 +4.26 (+1.67%)
Closing price 05/2/2025 04:00 PM Eastern
Extended Trading
$258.82 -0.57 (-0.22%)
As of 05/2/2025 06:53 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Recent Alnylam Pharmaceuticals SEC Filings

DateFilerForm TypeView
05/01/2025
7:09 AM
Alnylam Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/01/2025
7:15 AM
Alnylam Pharmaceuticals (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
04/07/2025
10:51 AM
Alnylam Pharmaceuticals (Subject)
VANGUARD GROUP INC (Filed by)
Form SCHEDULE 13G/A
03/24/2025
4:00 PM
Alnylam Pharmaceuticals (Filer)
Form DEFA14A
03/24/2025
4:02 PM
Alnylam Pharmaceuticals (Filer)
Form ARS
03/24/2025
3:40 PM
Alnylam Pharmaceuticals (Filer)
Form DEF 14A
03/24/2025
3:13 PM
Alnylam Pharmaceuticals (Subject)
PYOTT DAVID E I (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
03/14/2025
3:16 PM
Alnylam Pharmaceuticals (Filer)
Form PRE 14A
03/14/2025
3:16 PM
Alnylam Pharmaceuticals (Issuer)
SCHULMAN AMY W (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/03/2025
3:31 PM
Alnylam Pharmaceuticals (Issuer)
Garg Pushkal (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/03/2025
3:31 PM
Alnylam Pharmaceuticals (Issuer)
Tanguler Tolga (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/03/2025
3:31 PM
Alnylam Pharmaceuticals (Issuer)
Poulton Jeffrey V. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
03/03/2025
3:32 PM
Alnylam Pharmaceuticals (Issuer)
Greenstreet Yvonne (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/13/2025
1:14 PM
Alnylam Pharmaceuticals (Subject)
Capital Research Global Investors (Filed by)
Form SCHEDULE 13G
02/13/2025
7:31 AM
Alnylam Pharmaceuticals (Filer)
Form 10-K
Annual report pursuant to Section 13 or 15(d)  
02/13/2025
7:09 AM
Alnylam Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
01/27/2025
3:01 PM
Alnylam Pharmaceuticals (Subject)
Garg Pushkal (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
01/23/2025
3:17 PM
Alnylam Pharmaceuticals (Subject)
SHARP PHILLIP A (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
01/13/2025
6:31 AM
Alnylam Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
12/13/2024
3:13 PM
Alnylam Pharmaceuticals (Issuer)
Garg Pushkal (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
11/27/2024
4:20 PM
Alnylam Pharmaceuticals (Issuer)
Fitzgerald Kevin Joseph (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
11/27/2024
4:21 PM
Alnylam Pharmaceuticals (Issuer)
Tanguler Tolga (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
11/27/2024
4:21 PM
Alnylam Pharmaceuticals (Issuer)
Poulton Jeffrey V. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
11/27/2024
4:22 PM
Alnylam Pharmaceuticals (Issuer)
Garg Pushkal (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
11/27/2024
4:22 PM
Alnylam Pharmaceuticals (Issuer)
Greenstreet Yvonne (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
11/27/2024
3:06 PM
Alnylam Pharmaceuticals (Subject)
Fitzgerald Kevin Joseph (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
11/08/2024
9:34 AM
Alnylam Pharmaceuticals (Subject)
WELLINGTON MANAGEMENT GROUP LLP (Filed by)
Form SC 13G/A
10/31/2024
7:10 AM
Alnylam Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
10/31/2024
7:22 AM
Alnylam Pharmaceuticals (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
10/03/2024
3:11 PM
Alnylam Pharmaceuticals (Issuer)
Hesslein Robert W. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
08/22/2024
7:01 PM
Alnylam Pharmaceuticals (Issuer)
Greenstreet Yvonne (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
08/20/2024
4:10 PM
Alnylam Pharmaceuticals (Subject)
Greenstreet Yvonne (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
08/12/2024
8:40 AM
Alnylam Pharmaceuticals (Subject)
FMR LLC (Filed by)
Form SC 13G/A
08/02/2024
7:01 PM
Alnylam Pharmaceuticals (Issuer)
Greenstreet Yvonne (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
08/01/2024
7:22 AM
Alnylam Pharmaceuticals (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
08/01/2024
7:11 AM
Alnylam Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
07/12/2024
7:02 PM
Alnylam Pharmaceuticals (Issuer)
Greenstreet Yvonne (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
07/11/2024
3:40 PM
Alnylam Pharmaceuticals (Subject)
Greenstreet Yvonne (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
07/05/2024
9:24 AM
Alnylam Pharmaceuticals (Subject)
BAILLIE GIFFORD & CO (Filed by)
Form SC 13G/A
05/31/2024
6:00 PM
Alnylam Pharmaceuticals (Issuer)
SCHULMAN AMY W (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/20/2024
3:34 PM
Alnylam Pharmaceuticals (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
Trump Makes Major Crypto Announcement (Ad)

Trump's Pro-Crypto Agenda Finally Sparks Market Recovery With Bitcoin surging past $90,000 and altcoins heating up, I'm seeing all the signs of a major market shift For a limited time, I'm revealing the name and complete analysis behind my top Trump-era crypto pick.

(Data available from 1/1/2016 forward)


Related Companies and Tools


This page (NASDAQ:ALNY) was last updated on 5/4/2025 by MarketBeat.com Staff
From Our Partners